Functional outcomes for clinical trials in frail older persons: Time to be moving

William J. Evans, Shalender Bhasin, Elaine Cress, Mark A. Espeland, Luigi Ferrucci, Linda P Fried, Thomas M. Gill, Marco Pahor, Stephanie Studenski, Jack Guralnik, Susan Nayfield, Sergei Romashkin, Basil A. Eldadah, Richard Suzman, John Haaga, Robert Perlstein, Laurie Burke, Mary Parks

Research output: Contribution to journalArticle

Abstract

This is an exciting time with great potential for discovering therapies to improve functional capacity and decrease the high prevalence of frailty and disability in older people. The FDA will need to consider how best to incorporate the geriatric perspective into its mission. Cooperation between aging researchers, pharmaceutical companies, and regulators will be required to establish guidelines for outcome measures for the coming generation of clinical trials in frail older persons. Ultimately, all stakeholders have the same goals: reducing the burden of chronic disease and disability in older persons while avoiding harm.

Original languageEnglish (US)
Pages (from-to)160-164
Number of pages5
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume63
Issue number2
StatePublished - Feb 2008

Fingerprint

Clinical Trials
Geriatrics
Chronic Disease
Research Personnel
Outcome Assessment (Health Care)
Guidelines
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Aging

Cite this

Functional outcomes for clinical trials in frail older persons : Time to be moving. / Evans, William J.; Bhasin, Shalender; Cress, Elaine; Espeland, Mark A.; Ferrucci, Luigi; Fried, Linda P; Gill, Thomas M.; Pahor, Marco; Studenski, Stephanie; Guralnik, Jack; Nayfield, Susan; Romashkin, Sergei; Eldadah, Basil A.; Suzman, Richard; Haaga, John; Perlstein, Robert; Burke, Laurie; Parks, Mary.

In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 63, No. 2, 02.2008, p. 160-164.

Research output: Contribution to journalArticle

Evans, WJ, Bhasin, S, Cress, E, Espeland, MA, Ferrucci, L, Fried, LP, Gill, TM, Pahor, M, Studenski, S, Guralnik, J, Nayfield, S, Romashkin, S, Eldadah, BA, Suzman, R, Haaga, J, Perlstein, R, Burke, L & Parks, M 2008, 'Functional outcomes for clinical trials in frail older persons: Time to be moving', Journals of Gerontology - Series A Biological Sciences and Medical Sciences, vol. 63, no. 2, pp. 160-164.
Evans, William J. ; Bhasin, Shalender ; Cress, Elaine ; Espeland, Mark A. ; Ferrucci, Luigi ; Fried, Linda P ; Gill, Thomas M. ; Pahor, Marco ; Studenski, Stephanie ; Guralnik, Jack ; Nayfield, Susan ; Romashkin, Sergei ; Eldadah, Basil A. ; Suzman, Richard ; Haaga, John ; Perlstein, Robert ; Burke, Laurie ; Parks, Mary. / Functional outcomes for clinical trials in frail older persons : Time to be moving. In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2008 ; Vol. 63, No. 2. pp. 160-164.
@article{c0f8b2cfec5545149f5d3678769eb821,
title = "Functional outcomes for clinical trials in frail older persons: Time to be moving",
abstract = "This is an exciting time with great potential for discovering therapies to improve functional capacity and decrease the high prevalence of frailty and disability in older people. The FDA will need to consider how best to incorporate the geriatric perspective into its mission. Cooperation between aging researchers, pharmaceutical companies, and regulators will be required to establish guidelines for outcome measures for the coming generation of clinical trials in frail older persons. Ultimately, all stakeholders have the same goals: reducing the burden of chronic disease and disability in older persons while avoiding harm.",
author = "Evans, {William J.} and Shalender Bhasin and Elaine Cress and Espeland, {Mark A.} and Luigi Ferrucci and Fried, {Linda P} and Gill, {Thomas M.} and Marco Pahor and Stephanie Studenski and Jack Guralnik and Susan Nayfield and Sergei Romashkin and Eldadah, {Basil A.} and Richard Suzman and John Haaga and Robert Perlstein and Laurie Burke and Mary Parks",
year = "2008",
month = "2",
language = "English (US)",
volume = "63",
pages = "160--164",
journal = "Journals of Gerontology - Series A Biological Sciences and Medical Sciences",
issn = "1079-5006",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Functional outcomes for clinical trials in frail older persons

T2 - Time to be moving

AU - Evans, William J.

AU - Bhasin, Shalender

AU - Cress, Elaine

AU - Espeland, Mark A.

AU - Ferrucci, Luigi

AU - Fried, Linda P

AU - Gill, Thomas M.

AU - Pahor, Marco

AU - Studenski, Stephanie

AU - Guralnik, Jack

AU - Nayfield, Susan

AU - Romashkin, Sergei

AU - Eldadah, Basil A.

AU - Suzman, Richard

AU - Haaga, John

AU - Perlstein, Robert

AU - Burke, Laurie

AU - Parks, Mary

PY - 2008/2

Y1 - 2008/2

N2 - This is an exciting time with great potential for discovering therapies to improve functional capacity and decrease the high prevalence of frailty and disability in older people. The FDA will need to consider how best to incorporate the geriatric perspective into its mission. Cooperation between aging researchers, pharmaceutical companies, and regulators will be required to establish guidelines for outcome measures for the coming generation of clinical trials in frail older persons. Ultimately, all stakeholders have the same goals: reducing the burden of chronic disease and disability in older persons while avoiding harm.

AB - This is an exciting time with great potential for discovering therapies to improve functional capacity and decrease the high prevalence of frailty and disability in older people. The FDA will need to consider how best to incorporate the geriatric perspective into its mission. Cooperation between aging researchers, pharmaceutical companies, and regulators will be required to establish guidelines for outcome measures for the coming generation of clinical trials in frail older persons. Ultimately, all stakeholders have the same goals: reducing the burden of chronic disease and disability in older persons while avoiding harm.

UR - http://www.scopus.com/inward/record.url?scp=42449130997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42449130997&partnerID=8YFLogxK

M3 - Article

C2 - 18314451

AN - SCOPUS:42449130997

VL - 63

SP - 160

EP - 164

JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

SN - 1079-5006

IS - 2

ER -